Duvelisib Patent Expiration
Duvelisib is Used for treating chronic lymphocytic leukemia, small lymphocytic leukemia, and follicular lymphoma. It was first introduced by Secura Bio Inc
Duvelisib Patents
Given below is the list of patents protecting Duvelisib, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Copiktra | US11312718 | Formulations of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one | Jan 10, 2032 | Secura |
| Copiktra | US8193182 | Substituted isoquinolin-1(2H)-ones, and methods of use thereof | Feb 13, 2030 | Secura |
| Copiktra | US9216982 | Certain chemical entities, compositions and methods | Jan 05, 2029 | Secura |
| Copiktra | US9840505 | Solid forms of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1 (2H)-one and methods of use thereof | Jan 10, 2032 | Secura |
| Copiktra | USRE46621 | Processes for preparing isoquinolinones and solid forms of isoquinolinones | May 17, 2032 | Secura |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳